Mar. 16 at 3:35 AM
$KODK
The worst is clearly over! KODK has proven they can control costs and generate more pre-tax income and higher positive cash flow!
Bottom line:
For 2026 and thereafter, KODK must execute by:
1) Reducing interest expense by at least
$40-
$50 million dollars; this is huge!
2) Manufacturing more print technology related revenues in Rochester, NY, Columbus, GA and Germany, combined for at another
$1.3-
$1.5 billion dollars,
3) They must begin sourcing and manufacturing pharmaceuticals on beghalf of big pharma with a goal to generating at least
$1-
$2 billion in revenues,
4) Securing a US goverment contract and or UD investment and
5) Seriously consider putting themselves up for sale to the highest bidder!!!! This will ensure that Management is truly working for its shareholders!
Still buying more stock at these bargain basement prices! Very bullish!
